Project 170364
Understanding the role of the mitochondrial rhomboid protease in membrane dynamics
Understanding the role of the mitochondrial rhomboid protease in membrane dynamics
Project Information
| Study Type: | Trial Randomized_Controlled_Trial |
| Therapeutic Area: | Infectious_Disease |
| Research Theme: | Biomedical |
| Disease Area: | meningococcal disease prevention |
| Data Type: | Canadian |
Institution & Funding
| Principal Investigator(s): | Mcquibban, George A |
| Institution: | University of Toronto |
| CIHR Institute: | Genetics |
| Program: | |
| Peer Review Committee: | Cell Biology & Mechanisms of Disease |
| Competition Year: | 2008 |
| Term: | 5 yrs 0 mth |
Abstract Summary
Mitochondria are extremely dynamic organelles undergoing constant double membrane fusion and fission reactions. The control and mechanisms involved to regulate this activity are currently of great interest in both the health and the death of the cell. We have discovered the key action of the mitochondrial rhomboid protease in regulating membrane fusion. Rhomboids are highly conserved intramembrane proteases that process initially membrane tethered substrates. We have now identified three important substrates for the mitochondrial rhomboid: Mgm/OPA; a dynamin-related protein, Omi/HtrA2; a mitochondrial targeted protease, and Pink1; a mitochondrial targeted kinase. The rhomboid-dependent processing of these three proteins is required for their biological activities. Mutations in OPA cause the most prevalent early onset blindness mitochondrial disease called dominant optic atrophy; and both Pink1 and Omi have been linked to Parkinson's disease, underscoring the relevance of these discoveries. By undertaking a series of in vitro structure/function analyses, combined with in vivo assays in both yeast and flies, we hope to uncover the significance of the rhomboid cleavage event, and understand its relevance to mitochondrial function in human disease.
Research Characteristics
This project includes the following research characteristics:
Study Justification
"evaluate the effectiveness of meningococcal C conjugate vaccine programs in Canadian children"
Novelty Statement
"first study to compare effectiveness of different dosing schedules (1, 2, or 3 doses) of meningococcal vaccines"
Methodology Innovation
comparison of different provincial vaccination schedules